In this video, Dr. Elizabeth Swisher reviews the use of PARP inhibitors in breast cancer, and the importance of understanding how resistance to these agents develops.
Elizabeth Swisher, MD
Advertisement
Articles by Elizabeth Swisher, MD
Advertisement
Latest Updated Articles
Forecasting PARP Inhibitor Resistance in Breast Cancer PatientsPublished: April 23rd 2018 | Updated:
Advertisement
Advertisement
Trending on CancerNetwork
1
What Were the Key Presentations at ESMO 2025? Oncology Experts Discuss
2
Zipalertinib Yields Early Activity in EGFR+ NSCLC CNS Metastasis Population
3
Progress in the Treatment of Advanced-Stage Classical Hodgkin Lymphoma in the PET-Adapted Era
4
ctDNA Status May Determine Adjuvant Immunotherapy Benefit in MIBC
5
